Sustained Elevation of Intraocular Pressure After Administration of Intravitreal Anti-Vascular Endothelial Growth Factor Agents in Patients With and Without Pseudoexfoliation Syndrome

Ucgul A. Y., AKTAŞ Z., Ozgur A., Cubuk M. O., Hasanreisoglu M., ÖZDEK Ş., ...Daha Fazla

JOURNAL OF GLAUCOMA, cilt.29, sa.10, ss.981-988, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 10
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1097/ijg.0000000000001600
  • Dergi Adı: JOURNAL OF GLAUCOMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.981-988
  • Anahtar Kelimeler: anti-VEGF, bevacizumab, pseudoexfoliation, ranibizumab, sustained IOP elevation, MACULAR DEGENERATION, NITRIC-OXIDE, BEVACIZUMAB AVASTIN, RANIBIZUMAB LUCENTIS, FACTOR THERAPY, INJECTION, EYES
  • Gazi Üniversitesi Adresli: Evet

Özet

Precis: Intravitreal anti-vascular endothelial growth factor therapy resulted in sustained elevation of intraocular pressure (IOP) in 18.6% of patients with coexisting age-related macular degeneration and pseudoexfoliation (PXF) syndrome. The development of sustained elevation of IOP after similar to 19 injections reflected the cumulative effect of anti-vascular endothelial growth factor injections on IOP.